Brent Neidig Sells 5,002 Shares of USANA Health Sciences (NYSE:USNA) Stock

USANA Health Sciences, Inc. (NYSE:USNA) insider Brent Neidig sold 5,002 shares of the stock in a transaction that occurred on Tuesday, June 16th. The stock was sold at an average price of $19.45, for a total transaction of $97,288.90. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

USANA Health Sciences Trading Up 0.6%

Shares of USNA opened at $19.00 on Friday. USANA Health Sciences, Inc. has a 12-month low of $16.60 and a 12-month high of $38.32. The business’s 50 day moving average is $18.77 and its 200 day moving average is $19.41. The company has a market capitalization of $350.74 million, a PE ratio of 40.43, a price-to-earnings-growth ratio of 0.74 and a beta of 0.76.

USANA Health Sciences (NYSE:USNA) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, beating analysts’ consensus estimates of $0.44 by $0.17. The company had revenue of $250.22 million during the quarter, compared to analyst estimates of $240.99 million. USANA Health Sciences had a return on equity of 6.21% and a net margin of 0.96%.USANA Health Sciences has set its FY 2026 guidance at 1.950-2.290 EPS. Equities research analysts predict that USANA Health Sciences, Inc. will post 2.12 earnings per share for the current year.

Institutional Investors Weigh In On USANA Health Sciences

Large investors have recently modified their holdings of the business. State of Alaska Department of Revenue grew its stake in USANA Health Sciences by 8.5% during the 4th quarter. State of Alaska Department of Revenue now owns 6,666 shares of the company’s stock worth $130,000 after buying an additional 525 shares during the last quarter. Russell Investments Group Ltd. boosted its holdings in shares of USANA Health Sciences by 4.6% in the fourth quarter. Russell Investments Group Ltd. now owns 12,431 shares of the company’s stock valued at $244,000 after acquiring an additional 542 shares in the last quarter. Quantbot Technologies LP grew its holdings in USANA Health Sciences by 19.5% during the second quarter. Quantbot Technologies LP now owns 3,957 shares of the company’s stock worth $121,000 after acquiring an additional 646 shares during the period. Intech Investment Management LLC grew its position in USANA Health Sciences by 13.5% during the third quarter. Intech Investment Management LLC now owns 7,722 shares of the company’s stock worth $213,000 after buying an additional 918 shares during the period. Finally, National Bank of Canada FI grew its holdings in USANA Health Sciences by 166.6% in the third quarter. National Bank of Canada FI now owns 1,922 shares of the company’s stock valued at $53,000 after purchasing an additional 1,201 shares during the last quarter. Hedge funds and other institutional investors own 54.25% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on USNA shares. Wall Street Zen upgraded USANA Health Sciences from a “hold” rating to a “buy” rating in a report on Saturday. Weiss Ratings reissued a “sell (d)” rating on shares of USANA Health Sciences in a research report on Friday, March 27th. Finally, Zacks Research lowered USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a report on Wednesday, April 22nd. One investment analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, USANA Health Sciences currently has an average rating of “Reduce”.

About USANA Health Sciences

USANA Health Sciences, Inc is a Utah‐based company that develops, manufactures and distributes nutritional supplements and personal care products through a network of independent distributors. Founded in 1992 by Dr. Myron Wentz, the company’s portfolio includes vitamins, minerals, dietary supplements, weight‐management products and skin‐care formulations. USANA’s products are formulated in its own laboratories to meet pharmaceutical‐grade standards, and the company has invested heavily in research and development and quality control to support its offerings.

Operating primarily through a direct selling model, USANA serves markets in North America, Asia Pacific, Europe and Latin America.